Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7812632rdf:typepubmed:Citationlld:pubmed
pubmed-article:7812632lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:7812632lifeskim:mentionsumls-concept:C0018338lld:lifeskim
pubmed-article:7812632lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:7812632lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7812632lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:7812632lifeskim:mentionsumls-concept:C0205359lld:lifeskim
pubmed-article:7812632lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:7812632pubmed:issue1lld:pubmed
pubmed-article:7812632pubmed:dateCreated1995-2-8lld:pubmed
pubmed-article:7812632pubmed:abstractTextFK409 ((+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide) , which has been reported by us to be a new spontaneous nitric oxide (NO) releaser, prevented myocardial infarction following occlusion and reperfusion in rat coronary artery and increased plasma cyclic GMP level in rats, dose-dependently and significantly at 32 mg kg-1. Isosorbide dinitrate (ISDN), which is the most popular orally active NO donor used in the treatment of ischaemic cardiovascular diseases, did not show significant effects at 32 mg kg-1 in either experiment. Therefore, it is suggested that FK409 can attenuate myocardial injury during ischaemia and reperfusion in contrast to ISDN and a change in plasma cyclic GMP level may serve as an indicator of the cardioprotective effect of NO-releasing drugs.lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:languageenglld:pubmed
pubmed-article:7812632pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:citationSubsetIMlld:pubmed
pubmed-article:7812632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7812632pubmed:statusMEDLINElld:pubmed
pubmed-article:7812632pubmed:monthSeplld:pubmed
pubmed-article:7812632pubmed:issn0007-1188lld:pubmed
pubmed-article:7812632pubmed:authorpubmed-author:YoshidaKKlld:pubmed
pubmed-article:7812632pubmed:authorpubmed-author:SugimotoTTlld:pubmed
pubmed-article:7812632pubmed:authorpubmed-author:MaedaKKlld:pubmed
pubmed-article:7812632pubmed:authorpubmed-author:HirasawaYYlld:pubmed
pubmed-article:7812632pubmed:authorpubmed-author:KitaYYlld:pubmed
pubmed-article:7812632pubmed:issnTypePrintlld:pubmed
pubmed-article:7812632pubmed:volume113lld:pubmed
pubmed-article:7812632pubmed:ownerNLMlld:pubmed
pubmed-article:7812632pubmed:authorsCompleteYlld:pubmed
pubmed-article:7812632pubmed:pagination5-6lld:pubmed
pubmed-article:7812632pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:meshHeadingpubmed-meshheading:7812632-...lld:pubmed
pubmed-article:7812632pubmed:year1994lld:pubmed
pubmed-article:7812632pubmed:articleTitleClose correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level.lld:pubmed
pubmed-article:7812632pubmed:affiliationDepartment of Pharmacology, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.lld:pubmed
pubmed-article:7812632pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7812632lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7812632lld:pubmed